Awards & Advancement

Teva appoints two to executive team

Friday, August 3, 2012 11:07 AM

Teva Pharmaceutical, a global pharmaceutical company based in Israel, has appointed Dr. Carlo De Notaristefani as president and CEO of global operations and Aharon (Arik) Yaari as executive vice president of newly created community and institutional affairs.

More... »

RxAlly adds Mike Groh as CIO

Thursday, August 2, 2012 03:33 PM

RxAlly, an alliance of more than 22,000 pharmacies nationwide, has appointed Michael J. Groh, PharmD, as chief information officer.

More... »

Endocyte appoints Novartis vet David Meek as chief commercial officer

Monday, July 30, 2012 03:49 PM

Endocyte, an Indianapolis, Ind.-based biopharmaceutical company focused on cancer and inflammatory diseases, has appointed David Meek to the newly created position of chief commercial officer. He will be responsible for the development of Endocyte’s commercial team and overall commercial strategy and execution.

More... »

Sidra Medical appoints William F. Owen Jr. as CEO

Thursday, July 26, 2012 04:18 PM

American healthcare leader Dr. William F. Owen, Jr., M.D., FACP, has been appointed CEO of Sidra Medical and Research Center, a Qatar-based medical, research and education institution that focuses on the health and well-being of women and children, effective August 5, 2012.

More... »

Quanticate adds new leadership to oversee expansion

Thursday, July 26, 2012 03:51 PM

Quanticate, a global data-focused clinical CRO, has appointed Sally Du Toit as vice president of pharmacovigilance and Chris Cramer as vice president of clinical data management.  

More... »

Former HHS assistant secretary joins West Health Policy Center

Friday, July 20, 2012 01:12 PM

Michael J. O'Grady, Ph.D., former HHS assistant secretary for planning and evaluation, has joined the West Health Policy Center as its inaugural president.  Launched by philanthropists Gary and Mary West earlier this year, the Center's mission is to develop common sense reimbursement and regulatory proposals to save the U.S. more than $100 billion in cumulative health care costs within 10 years.

More... »

Conatus Pharmaceuticals appoints Morris as head of biostatistics

Thursday, July 19, 2012 08:16 AM

Conatus Pharmaceuticals, a San Diego-based privately held biopharmaceutical company focused on fibrotic disease and oncology, has appointed Mark F. Morris as head of biostatistics.

More... »

RxAlly names Tom O'Grady to leadership team

Tuesday, July 17, 2012 12:12 PM

RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide, has named Tom O'Grady to its leadership team.  As general counsel and executive vice president of corporate development, O’Grady brings more than 30 years of corporate and transactional law experience. He will be structuring business relationships between RxAlly and the companies and businesses it will be working with as it continues to align pharmacies and pharmacists, the patients they serve and the payer community.

More... »

Kala Pharmaceuticals appoints Pfefer as president and CEO

Tuesday, July 17, 2012 08:09 AM

Kala Pharmaceuticals, a Waltham, Mass.-based developer of products that rapidly penetrate the mucosal barrier to treat a wide range of debilitating diseases, has appointed Guillaume Pfefer, PhD, as president, CEO and member of the board of directors.

More... »

PharmaNet/i3 names VP and general manager, neuroscience

Monday, July 16, 2012 11:05 AM

PharmaNet/i3, inVentiv Health’s clinical segment, has appointed Robert Lasser, M.D., MBA, vice president and general manager, neuroscience, overseeing the management of all clinical projects handled by PharmaNet/i3’s neuroscience group and the Rater Training Services team. Dr. Lasser will be based in Princeton, N.J.

More... »